Norma Hellas S.A. is a pharmaceutical company based in Greece that holds the marketing authorization for over 70 pharmaceutical products, with 46 of them already launched. The company is actively seeking approval for new products through national and mutual procedures. Additionally, Norma Hellas is dedicated to the development of new products and advanced pharmaceutical forms, conducted in research centers located in Greece and Europe. Primarily focused on healthcare products, the company distributes its offerings in the Greek market, as well as East Europe, Middle East, and Central Asia. Established in 1970, Norma Hellas S.A. solidifies its position in the branded generics area, aiming to develop and trade pharmaceutical products while upholding a strong commitment to the protection of public health and the improvement of human life quality.
There is no investment information
No recent news or press coverage available for Norma Hellas.
We care about your data, and we'd love to use cookies make your experience better.
